Her-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma

Human Pathology

Volumn 31, Issue 1, 2000, Pages 35-39

  Brien, Thomas P ^a,b   Odze, Robert D ^a,b   Sheehan, Christine E ^a,b   McKenna, Barbara J ^a,b   Ross, Jeffrey S ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Esophageal adenocarcinoma; FISH; HER 2 neu

Indexed keywords

CITRATE SODIUM; EPIDERMAL GROWTH FACTOR; SODIUM CHLORIDE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER SURVIVAL; CHROMOSOME 17Q; DISEASE SEVERITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; SURVIVAL RATE;

EID: 0033963379     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(00)80195-1     Document Type: Article

References (23)

1. Hesketh PJ Clapp RW Doos WG The increasing frequency of adenocarcinoma of the esophagus Cancer 64 1989 526 530
2. Blot WJ Devesa SS Fraumeni JF Jr Continuing climb in rates of esophageal adenocarcinoma: An update JAMA 270 1993 1320
3. Pera M Cameron AJ Trastek VF Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction Gastroenterology 104 1993 510 513
4. Devesa SS Blot WJ Fraumeni JF Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 1998 2049 2053
5. Berger MS Locher GW Saurer S Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading Cancer Res 48 1988 1238 1243
6. Battifora H Gaffey M Esteban J Immunohistochemical assay of neu /c- erb B-2 oncogene product in paraffin-embedded tissues in early breast cancer: Retrospective follow-up study of 245 stage I and II cases Mod Pathol 4 1991 466 474
7. Press MF Pike MC Chazin VR Her-2/ neu expression in node-negative breast cancer: Direct tissue quantification by computerized image analysis and association of overexpression with increased risk of recurrent disease Cancer Res 53 1993 4960 4970
8. Seshadri R Firgaira FA Horsfall DJ Clinical significance of HER-2/ neu oncogene amplification in primary breast cancer: The South Australian Breast Cancer Study Group J Clin Oncol 11 1993 1936 1942
9. Jankowski J Coghill G Hopwood D Oncogenes and oncosuppressor gene in adeonocarcinoma of the oesophagus Gut 33 1992 1033 1038
10. Al-Kasspooles M Moore JH Orringer MB Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas Int J Cancer 54 1993 213 219
11. Flejou JF Paraf F Muzeau F Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations J Clin Pathol 47 1994 23 26
12. Hardwick RH Shepherd NA Moorghen M c-erb-B-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus J Clin Pathol 48 1995 129 132
13. Duhaylongsod FG Gottfried MR Iglehart JD The significance of c-erbB2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus Ann Surg 221 1995 677 683
14. Hardwick RH Barham CP Ozua P Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis Eur J Surg Oncol 23 1997 30 35
15. Kim R Clarke MR Melhem MF Expression of p53, PCNA, and c-erbB2 in Barrett's metaplasia and adenocarcinoma Dis Dis Sci 42 1997 2453 2462
16. Nakamura T Nekarda H Hoelscher AH Prognostic value of DNA ploidy and c-erb-B-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus Cancer 73 1994 1785 1794
17. Kallioniemi OP Kallioniemi A Kurisu W ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization Proc Natl Acad Sci U S A 89 1992 5321 5325
18. Press MF Bernstein L Thomas PA Her-2/ neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas J Clin Oncol 15 1997 2894 2904
19. Ross JS Sheehan C Hayner-Buchan AM Prognostic significance of HER-2/ neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma Cancer 79 1997 2162 2170
20. Brien TP Depowski PD Sheehan CE Prognostic factors in gastric cancer Mod Pathol 11 1998 870 877
21. Riben MW Malfetano JH Nazeer T Identification of HER-2/ neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma Mod Pathol 10 1997 823 831
22. Slamon DJ Godolphin W Jones LA Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
23. Hayner-Buchan A Brien TP Sheehan CE HER-2/ neu oncogene amplification determined by fluorescence in-situ hybridization (FISH) is an independent predictor of survival in colorectal adenocarcinoma Mod Pathol 12 1999 76A